In the Media

BioElectronics In the Media

ActiPatch® OTC Chronic Pain Therapy Overview

BIOELECTRONICS CEO ANDREW WHELAN Interviewed on New Equity Network Talk Radio Show

Interview Part 1

Interview Part 2

ActiPatch® UK Commercial 2015

ActiPatch® Life Changing Pain Relief – Reviews & Testimonials

New ActiPatch® UK Commercial Released!

BioElectronics CEO Andrew Whelan Interviewed Live On Clear Channel Business Talk Radio

Below are the segments from the March 26 Clear Channel Business Talk Radio interview with BioElectronics CEO Andrew Whelan:

Segment 1: (10min, 01sec)
http://www.yorbamedia.com/images/stories/audio/TN032614SEG3.mp3

Segment 2: (9min, 35sec)
http://www.yorbamedia.com/images/stories/audio/TN032614SEG4.mp3

Smart Insole Wins High Commendation In “Most Innovative New OTC Product Award” From OTC Bulletin

“BioElectronics’ Smart Insole rides the wave of wearable tech’ that looks likely to crash into the consumer healthcare market. It offers an innovative way to deal with an unglamorous and difficult-to-treat problem.”

In Addition, Company Also Wins Runner-Up In Best Packaging Award For New ActiPatch® Therapy Box.

“The ActiPatch brand provides a striking and distinctive design to help differentiate this new and alternative product in a sector that is already dominated by other leading brands.”

ActiPatch® Pain Relief Therapy Featured on Leading Healthcare Show in Spain

ActiPatch® Cited for “Most Innovative New OTC Product” Award

The OTC Bulletin, the leading global trade publication for over-the-counter healthcare products has chosen its ActiPatch® Musculoskeletal Pain Relief Therapy as the first runner-up for the “Most Innovative New OTC Product.”

The OTC Bulletin is widely recognized as the most comprehensive trade publication for the consumer healthcare market in more than 45 countries. ActiPatch® Therapy placed second after Boots Pharmaceuticals Non-Contact Thermometer product.

A panel of six independent over-the-counter marketing experts evaluated all twelve nominees from some of the world’s leading pharmaceutical companies. One of the judges, Jerome Reinsten, former Director-General of the World Self-Medication Industry, remarked that ActiPatch Therapy was a “novel and previously unexplored route to topical pain therapy,” while another judge felt the product range was an “ingenious way of providing pain relief.”

The complete details on the award winners are available in the 2013 OTC Awards Supplement http://www.otc-bulletin.com/awards/pdfs/WinnersSupplement2013.pdf.